Vanguard Group’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Vanguard Group’s Portfolio VIE Stock Details VIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,012,749	Closed	-$72.4M	–	4352
2020 Q4	$72.4M	Buy	2,012,749 +34,885	+2%	+$1.22M	﹤0.01%	2006
2020 Q3	$55.5M	Sell	1,977,864 -80,044	-4%	-$2.83M	﹤0.01%	1964
2020 Q2	$89.1M	Buy	2,057,908 +1,820,242	+766%	+$82.4M	﹤0.01%	1735
2020 Q1	$9.03M	Sell	237,666 -2,971	-1%	-$116K	﹤0.01%	2668
2019 Q4	$6.53M	Buy	+240,637	New	+$6.06M	﹤0.01%	3067

Vanguard Group's VIE Position: Q1 2021 in Review

Vanguard Group sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 2,012,749 shares — an estimated $72.4M sold.

Vanguard Group first reported a position in VIE in Q4 2019 and held it in 5 quarters. The position peaked at $89.1M in Q2 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

Vanguard Group reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Vanguard Group sold 2,012,749 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $72.4M.
Vanguard Group first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
Vanguard Group's Viela Bio, Inc. Common Stock position peaked at $89.1M in Q2 2020.
0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on Vanguard Group's 13F filing for Q1 2021, filed 14 May 2021.